Back to Agendas
Closing Session: Question and Answer Session with FDA
Session Chair(s)
Lucy Rose, MBA
President
Lucy Rose and Associates, United States
Use this unique opportunity to bring your pressing questions for FDA to address in person. This session will attempt to answer any remaining questions from earlier sessions and to allow the audience to ask new questions to our FDA speakers.
Speaker(s)
Thomas W. Abrams, MBA, RPh
Former FDA, United States
Retired, Director, Office of Prescription Drug Promotion, OMP, CDER
Julie Chronis, JD
FDA, United States
Regulatory Counsel, Office of Prescription Drug Promotion, CDER
Jean-Ah Kang, PharmD
FDA, United States
Special Assistant to the Director, Office of Prescription Drug Promotion, CDER
Robyn C. Tyler, JD, PharmD
FDA, United States
Lead Regulatory Counsel, Office of Prescription Drug Promotion, CDER
Kaylynn S. Yoon, JD, MHS
FDA, United States
Regulatory Counsel, CDER
Lisa Stockbridge, PhD
FDA, United States
Branch Chief, Advertising and Promotional Labeling Branch, OCBQ, CBER
Dorothy McAdams
FDA/CMV, United States
Supervisor VMO
Deborah Wolf, JD
FDA, United States
Regulatory Counsel, OPEQ , Regulatory Policy, CDRH
Have an account?